Walleye Capital’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Walleye Capital’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-54,930	Closed	-$978	–	4612
2022 Q4	$978	Hold	54,930	–	–	﹤0.01%	3056
2022 Q3	$5K	Hold	54,930	–	–	﹤0.01%	2952
2022 Q2	$4K	Hold	54,930	–	–	﹤0.01%	2176
2022 Q1	$11K	Buy	54,930 +363	+0.7%	+$109	﹤0.01%	2087
2021 Q4	$29K	Buy	+54,567	New	+$30.9K	﹤0.01%	1858

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Walleye Capital's IBER.WS Position: Q1 2023 in Review

Walleye Capital sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 54,930 shares — an estimated $978 sold.

Walleye Capital first reported a position in IBER.WS in Q4 2021 and held it in 5 quarters. The position peaked at $29K in Q4 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Walleye Capital reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 54,930 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $978.
Walleye Capital first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
Walleye Capital's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $29K in Q4 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.